Drugs Made In America Acquisition II Corp. (DMII)
10.22
+0.02
(+0.15%)
USD |
NASDAQ |
Nov 04, 16:00
Drugs Made In America Acquisition II Enterprise Value : 651.61M for Nov. 4, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2026 | 651.61M |
| November 03, 2026 | 650.65M |
| November 02, 2026 | 650.65M |
| October 30, 2026 | 650.02M |
| October 29, 2026 | 650.02M |
| October 28, 2026 | 649.70M |
| October 27, 2026 | 649.70M |
| October 26, 2026 | 649.70M |
| October 23, 2026 | 649.38M |
| October 22, 2026 | 649.38M |
| October 21, 2026 | 649.38M |
| October 20, 2026 | 649.06M |
| October 19, 2026 | 648.42M |
| October 16, 2026 | 648.74M |
| October 15, 2026 | 649.38M |
| October 14, 2026 | 649.38M |
| October 13, 2026 | 649.38M |
| October 12, 2026 | 649.38M |
| October 09, 2026 | 649.38M |
| October 08, 2026 | 649.38M |
| October 07, 2026 | 649.38M |
| October 06, 2026 | 649.06M |
| October 05, 2026 | 649.38M |
| October 02, 2026 | 649.38M |
| October 01, 2026 | 649.38M |
| Date | Value |
|---|---|
| September 30, 2026 | 648.74M |
| September 29, 2026 | 648.42M |
| September 28, 2026 | 647.47M |
| September 25, 2026 | 647.47M |
| September 24, 2026 | 646.83M |
| September 23, 2026 | 647.47M |
| September 22, 2026 | 647.15M |
| September 21, 2026 | 647.15M |
| September 18, 2026 | 648.10M |
| September 17, 2026 | 648.42M |
| September 16, 2026 | 647.47M |
| September 15, 2026 | 648.10M |
| September 14, 2026 | 648.74M |
| September 11, 2026 | 647.65M |
| September 10, 2026 | 648.10M |
| September 09, 2026 | 647.47M |
| September 08, 2026 | 647.79M |
| September 04, 2026 | 648.10M |
| September 03, 2026 | 648.10M |
| September 02, 2026 | 648.10M |
| September 01, 2026 | 647.15M |
| August 31, 2026 | 646.83M |
| August 28, 2026 | 646.19M |
| August 27, 2026 | 646.19M |
| August 26, 2026 | 644.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Acme United Corp. | 310.25M |
| American Shared Hospital Services | 24.61M |
| Avalon Holdings Corp. | 38.24M |
| Flanigan's Enterprises, Inc. | 163.57M |
| Bar Harbor Bankshares | 870.14M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 4.396M |
| Total Expenses (Quarterly) | -4.396M |
| EPS Diluted (Quarterly) | 0.069 |
| Earnings Yield | 1.99% |
| Normalized Earnings Yield | 1.932 |